<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate™ for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

1 min read

European Society of Gene & Cell Therapy, Oct 11-14, 2022

European Society of Gene & Cell Therapy, Oct 11-14, 2022

Date: October 11-14, 2022
Location: Edinburgh, Scotland
Event Website: www.esgctcongress.com
Organizer: European Society of Gene and Cell Therapy

Meet with our Team Members

Contact us to schedule a meeting

About our Cell & Gene Therapy Services

We develop and manufacture diverse cell therapies including CD34+ hematopoietic stem cells, autologous and allogenic T-cells, and NK cells. Our cell therapy capabilities cover numerous technologies, ranging from closed to open systems at different scales, depending on client needs. We also develop and manufacture adeno-associated viral vectors, lenti viral vectors and retro viral vectors. Our ready-to-use platform capabilities are built on cell factories (up to 48L) and bioreactors (up to 200L) using adherent processes, designed entirely in-house. 

Learn more about our Cell Therapy and Viral Vector services

About the Event

Each year, over 100 world-leading experts present their latest research at ESGCT. From Nobel Prize winners to scientists at the very cutting-edge of the field; ESGCT’s Annual Congress features the hot topics and ground-breaking research in gene and cell therapy.